Usafsam/PH - roche immuno and chlamydia trachomatis/neisseria gonorrhoeae blanket purchasing agreement reagents, kits and consumables
Ended Awarded Last action
- Contract number
- FA239625FB115
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $321,588
Award facts
- Contract value 100% obligated
- $321,587.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- WPAFB, OH 45433, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $321,588 |
About this award
The Defense Health Agency awarded Roche Diagnostics Corporation a $321,587.98 firm fixed-price blanket purchase agreement (BPA) call for immunological and Chlamydia trachomatis/Neisseria gonorrhoeae diagnostic reagents, kits, and consumables. This Call 0002, issued in January 2025 with an ultimate completion date of May 5, 2025, represents a child contract under Roche's existing BPA vehicle with the Defense Health Agency and supports diagnostic testing capabilities at Wright-Patterson Air Force Base, Ohio. The award was made through open competition with no set-aside designation, reflecting Roche Diagnostics' established position as a primary supplier of advanced diagnostic solutions to the Department of Defense healthcare system.
Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostic systems, laboratory instruments, and associated medical products serving federal healthcare agencies. The company maintains an extensive portfolio of federal contracts across the Defense Health Agency, Department of Veterans Affairs, and other civilian healthcare entities, delivering molecular diagnostics, immunochemistry testing, and infectious disease detection platforms. This procurement supports the Defense Health Agency's clinical laboratory operations and aligns with broader federal healthcare initiatives requiring reliable diagnostic capabilities for sexually transmitted infection testing and immunological assessments across military treatment facilities.
Quick answers
Who was awarded contract FA239625FB115?
FA239625FB115 was awarded to Roche Diagnostics Corporation by Air Force (Department of Defense) on May 2, 2025.
How much is contract FA239625FB115 worth?
The government has obligated $321,588 on FA239625FB115.
Which agency awarded contract FA239625FB115?
Air Force (Department of Defense) awarded FA239625FB115, with funding from Defense Health Agency (Department of Defense).
Is contract FA239625FB115 an order under another contract?
Yes. FA239625FB115 is a BPA call under FA239625AB002, a blanket purchase agreement.
Was contract FA239625FB115 competed?
The extent of competition for FA239625FB115 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award